Free Trial

BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Purchased by BNP Paribas Financial Markets

BrightSpring Health Services logo with Medical background

BNP Paribas Financial Markets raised its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 1,193.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 275,983 shares of the company's stock after acquiring an additional 254,654 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.16% of BrightSpring Health Services worth $4,700,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of BTSG. Schonfeld Strategic Advisors LLC lifted its position in shares of BrightSpring Health Services by 30.3% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 44,400 shares of the company's stock worth $756,000 after purchasing an additional 10,327 shares in the last quarter. Northern Trust Corp increased its stake in BrightSpring Health Services by 12.6% during the 4th quarter. Northern Trust Corp now owns 535,334 shares of the company's stock worth $9,117,000 after buying an additional 60,111 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in BrightSpring Health Services by 7.7% during the 4th quarter. The Manufacturers Life Insurance Company now owns 211,361 shares of the company's stock worth $3,599,000 after buying an additional 15,154 shares in the last quarter. Quarry LP purchased a new position in BrightSpring Health Services in the 4th quarter valued at approximately $29,000. Finally, Voya Investment Management LLC grew its stake in shares of BrightSpring Health Services by 931.8% in the fourth quarter. Voya Investment Management LLC now owns 183,277 shares of the company's stock worth $3,121,000 after acquiring an additional 165,515 shares in the last quarter.

BrightSpring Health Services Trading Up 4.0%

NASDAQ:BTSG opened at $23.24 on Wednesday. BrightSpring Health Services, Inc. has a 1 year low of $10.15 and a 1 year high of $24.82. The stock has a market cap of $4.05 billion, a P/E ratio of -89.38 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The stock has a 50-day simple moving average of $18.16 and a 200-day simple moving average of $18.82.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.10. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The business had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same quarter in the previous year, the firm earned $0.12 EPS. The company's revenue was up 25.9% compared to the same quarter last year. As a group, analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Morgan Stanley increased their price objective on BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. UBS Group upped their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Wells Fargo & Company lifted their price objective on BrightSpring Health Services from $25.00 to $27.00 and gave the company an "overweight" rating in a research note on Tuesday. Finally, Mizuho set a $26.00 price objective on BrightSpring Health Services in a research report on Monday, May 5th. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.56.

Get Our Latest Report on BTSG

BrightSpring Health Services Profile

(Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Read More

Want to see what other hedge funds are holding BTSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report).

Institutional Ownership by Quarter for BrightSpring Health Services (NASDAQ:BTSG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BrightSpring Health Services Right Now?

Before you consider BrightSpring Health Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.

While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines